4.6 Article

Heparin-fibronectin interactions in the development of extracellular matrix insolubility

Journal

MATRIX BIOLOGY
Volume 67, Issue -, Pages 107-122

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.matbio.2017.11.012

Keywords

Fibronectin; Heparin; Extracellular matrix; Glycosaminoglycans; Matrix assembly

Funding

  1. National Institutes of Health (NIH) [R01 CA160611]
  2. NIH pre-doctoral training grant [T32 GM007388]
  3. NIH NRSA fellowship [F32 GM077891]
  4. NIH Pathway to Independence Award [NIBIB: 4 R00 EB013446]
  5. NIH Director's New Innovator Award [1DP2HD087954]
  6. Program of Excellence in Glycosciences [PEG] [NHLBI: 4P01HL107150]

Ask authors/readers for more resources

During extracellular matrix (ECM) assembly, fibronectin (FN) fibrils are irreversibly converted into a detergent insoluble form which, through FN's multi-domain structure, can interact with collagens, matricellular proteins, and growth factors to build a definitive matrix. FN also has heparin/heparan sulfate (HS) binding sites. Using HS-deficient CHO cells, we show that the addition of soluble heparin significantly increased the amount of FN matrix that these cells assemble. Sulfated HS glycosaminoglycan (GAG) mimetics similarly increased FN assembly and demonstrated a dependence on GAG sulfation. The length of the heparin chains also plays a role in assembly. Chains of sufficient length to bind to two FN molecules gave maximal stimulation of assembly whereas shorter heparin had less of an effect. Using a decellularized fibroblast matrix for proteolysis, detergent fractionation, and mass spectrometry, we found that the predominant domain within insoluble fibril fragments is FN's major heparin-binding domain HepII (modules III12-14). Multiple HepII domains bind simultaneously to a single heparin chain in size exclusion chromatography analyses. We propose a model in which heparin/HS binding to the HepII domain connects multiple FNs together to facilitate the formation of protein interactions for insoluble fibril assembly. (C) 2017 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available